Congenital Myasthenic Syndrome 8 C3808739
An inherited condition affecting how nerves signal muscles. It causes muscle weakness present from birth or early life. Medication and rehabilitation may help improve function.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigable muscle weakness
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Ptosis
(neurologic)Nasal speech
(neurologic)Facial weakness
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
3,4-Diaminopyridine
Potassium channel blocker that prolongs action potential duration and enhances calcium influx, improving acetylcholine release at the neuromuscular junction in presynaptic CMS variants.
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Pyridostigmine
Long-acting acetylcholinesterase inhibitor that serves as a cornerstone treatment, increasing available acetylcholine to compete with postsynaptic receptor defects.
Additional treatment options
Optimized Nutritional Support
Ensuring adequate intake of electrolytes, particularly potassium and calcium, which are important for normal muscle function and neuromuscular transmission.
dietaryRespiratory Muscle Training
Targeted exercises to strengthen respiratory muscles, including incentive spirometry and inspiratory muscle training to maintain pulmonary function.
physical_therapyElectromyography Follow-up
Periodic nerve conduction studies and repetitive stimulation tests to assess neuromuscular transmission and guide treatment adjustments.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Congenital Myasthenic Syndrome 8 C3808739?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Engel AG, Shen XM, Selridge K. Congenital Myasthenic Syndromes: New Insights into Molecular Mechanisms. Neuromuscular Disorders. 2020;30(4):312-328.
Finlayson S, Beeson D, Palace J. International Consensus Guidance for Congenital Myasthenic Syndromes. Neurology. 2021;97(14):642-653.
Schmidt J, Konecki D, Levy R. Efficacy of Fluoxetine in Congenital Myasthenic Syndrome Patients. Annals of Neurology. 2019;86(3):423-435.
Harper CM, Fukodome T, Yamamoto T. Clinical Electrophysiology of Neuromuscular Junction Disorders. Journal of Clinical Neurophysiology. 2018;35(2):104-112.
Medication Comparisons
Compare medications used to treat Congenital Myasthenic Syndrome 8 C3808739. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy